Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/151853/1/bjs550180_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/151853/2/bjs550180.pd
Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer and a leading cause of cancer death...
Funding Information: Acknowledgments: Special thanks to Celso Matos, MD/PhD, for assistance with man...
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable...
Background: Surveillance of individuals at high risk of pancreatic ductal adenocarcinoma (PDAC) and ...
Surveillance of CDNK2A mutation carriers is relatively successful, detecting most PDACs at a resecta...
BackgroundPatients with chronic pancreatitis (CP) have an increased risk of pancreatic cancer. We pr...
Background: Data on surveillance for pancreatic ductal adenocarcinoma (PDAC) in high-risk individual...
INTRODUCTION:Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesions ...
INTRODUCTION: Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesion...
This is the peer reviewed version of the following article: Gomez‐Rubio, P. , Piñero, J. , Molina‐Mo...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137278/1/jso24582_am.pdfhttps://deepbl...
Pancreatic cancer is the fourth leading cause of cancer-related death in both sexes in the United St...
BACKGROUND & AIMS: To successfully implement imaging-based pancreatic cancer (PC) surveillance, unde...
Pancreatic cancer, despite significant medical advances, is still a significant clinical problem. Th...
Background: Pancreatic cancer is a malignant and complex tumor that often leads to an adverse progno...
Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer and a leading cause of cancer death...
Funding Information: Acknowledgments: Special thanks to Celso Matos, MD/PhD, for assistance with man...
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable...
Background: Surveillance of individuals at high risk of pancreatic ductal adenocarcinoma (PDAC) and ...
Surveillance of CDNK2A mutation carriers is relatively successful, detecting most PDACs at a resecta...
BackgroundPatients with chronic pancreatitis (CP) have an increased risk of pancreatic cancer. We pr...
Background: Data on surveillance for pancreatic ductal adenocarcinoma (PDAC) in high-risk individual...
INTRODUCTION:Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesions ...
INTRODUCTION: Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesion...
This is the peer reviewed version of the following article: Gomez‐Rubio, P. , Piñero, J. , Molina‐Mo...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137278/1/jso24582_am.pdfhttps://deepbl...
Pancreatic cancer is the fourth leading cause of cancer-related death in both sexes in the United St...
BACKGROUND & AIMS: To successfully implement imaging-based pancreatic cancer (PC) surveillance, unde...
Pancreatic cancer, despite significant medical advances, is still a significant clinical problem. Th...
Background: Pancreatic cancer is a malignant and complex tumor that often leads to an adverse progno...
Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer and a leading cause of cancer death...
Funding Information: Acknowledgments: Special thanks to Celso Matos, MD/PhD, for assistance with man...
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable...